This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: Dauntel S Verwijs: Innovator in Pharmaceutical Compositions
Introduction
Dauntel S Verwijs is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer and other diseases. With a total of 2 patents, his work focuses on developing novel pharmaceutical compositions that aim to improve patient outcomes.
Latest Patents
Verwijs's latest patents include innovative pharmaceutical compositions designed for the treatment of cancer and various other disorders. These inventions provide novel formulations that are suitable for bulk production of oral pharmaceutical dosage forms. The compositions are aimed at treating patients suffering from conditions involving cell survival, proliferation, and migration, including chronic inflammatory proliferative disorders, proliferative ocular disorders, benign proliferative disorders, and cancer.
Career Highlights
Dauntel S Verwijs is currently associated with Millennium Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatment options for patients facing serious health challenges.
Collaborations
Throughout his career, Verwijs has collaborated with esteemed colleagues such as Vijayalakshmi Ramanan and Irene Sophie Tobias. These partnerships have contributed to the success of his innovative projects and have fostered a collaborative environment for research and development.
Conclusion
Dauntel S Verwijs stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing effective treatments for cancer and other diseases. His contributions are paving the way for advancements in patient care and pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
